Akari Therapeutics Payables and Accrued Expenses (Quarterly) Insights

Akari Therapeutics Plc (AKTX)

0.2466 0.00 (0.00%) USD | NASDAQ | Mar 05, 16:00

0.249 0.00 (0.00%) Pre-Market: 09:01

View Payables and Accrued Expenses (Quarterly) for AKTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Payables and Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Payables and Accrued Expenses (Quarterly) Benchmarks

Start Trial

DBV Technologies SA	Upgrade
Cellectis SA	Upgrade
Biodexa Pharmaceuticals Plc	Upgrade
NuCana Plc	Upgrade
Autolus Therapeutics Plc	Upgrade